SAGE-217
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for SAGE-217, covering 2020-11-23 to 2024-07-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD) [Phase 3]